Topic summary

TB-500 and thymosin beta-4: the fragment versus the protein

Compounds › Repair & healing peptides observational data TB-500 BPC-157 preprint

This is a generated summary. It shows the 9 most-liked posts from a topic of 119, in their original order, with the accepted answer included where one exists. It is a reading aid and it will miss nuance — the full topic is the record.

c.okaforTL3Regular21 Apr 2025#1

TB-500 and thymosin beta-4: the fragment versus the protein Writing it up because I had to work it out twice and would rather nobody else did.

TB-500 and thymosin beta-4: what I expected, what I found, and the gap between them.

I am posting the gap rather than a theory about it. My theories about gaps like this one have not held up well.

57 likes 15mo

m.haddadTL2Regular8 May 2025#10

TB-500 is a fragment rather than the whole thymosin beta-4 protein, and the two are used interchangeably in product descriptions when they should not be. The fragment is what is generally supplied.

30 likes 15mo

r.mwangiTL213 May 2025#13

Post #10 is right about the mechanism and I think understates the practical bit.

TB-500 is usually the 7-residue actin-binding fragment of thymosin beta-4, not the full 43-residue protein. The two are routinely conflated in supplier documentation and in the literature. Evidence about the full protein does not automatically apply to the fragment.

31 likes 15mo

a.cabreraTL213 Jun 2025#38

Answering the question post #34 raises rather than the one it answers.

Route arguments — local versus systemic — are made confidently in this subcategory on very little published basis. The honest position is that the comparison has not been studied in humans.

I have kept the units in throughout, for the obvious reason.

28 likes 13mo

h.brandtTL223 Jun 2025#48

v.stanescu, post #5: Helpful, and short, which on this subject is harder than long. Go to post

One more thing on TB-500 and thymosin beta-4 that took me far too long to see: the two figures people quote are not measuring the same quantity. Once you notice that, the apparent contradiction disappears.

31 likes in reply to #5 13mo

f.novakTL25 Jul 2025#59

TB-500 is a fragment rather than the whole thymosin beta-4 protein, and the two are used interchangeably in product descriptions when they should not be. The fragment is what is generally supplied.

It is worth checking rather than assuming, which costs nothing.

32 likes 13mo

m.amankwahTL213 Jul 2025 · edited#67

r.venkatesan, post #41: I would call the community position on TB-500 and thymosin beta-4 likely rather than established, and I would be comfortable defending that hedge. Go to post

Nothing in this subcategory is medical advice and several members here are describing experiments on themselves. Both of those things should be stated plainly rather than implied.

Happy to expand any of that if it is the useful part.

33 likes in reply to #41 13mo

e.silvaTL228 Jul 2025#83

Bramley, post #12: The pentadecapeptide sequence is short and stable enough to survive conditions that would degrade a larger peptide, which is one of the few things about it that is well characterised. If that is already documented somewhere, ignore me and link it. Go to post

The lyophilised cake is worth looking at before adding diluent. A collapsed or shrunken cake is not a purity finding but it does say something about how the vial was made and how it travelled.

This is the version I would want a new member to read first.

30 likes in reply to #12 12mo

n.nybergTL220 Aug 2025#109

Taking post #108 at face value and following it one step further.

Nothing in this subcategory is medical advice and several members here are describing experiments on themselves. Both of those things should be stated plainly rather than implied.

Not a strong opinion, just a consistent one.

28 likes 11mo

Read the full topic (119 posts)

This topic was referenced in

TB-500 and thymosin beta-4: the fragment versus the protein — does this still hold?Compounds › Repair & healing peptides · 23 replies
Why plausible mechanism is not evidence of effect — one year onCompounds › Repair & healing peptides · 7 replies

Suggested topics

Topic	Participants	Replies	Views	Activity
What would change my mind about repair peptides: a specific answer Compounds › Repair & healing peptides TB-500 needs a source preprint Under review What would change my mind about repair peptides: a specific answer — that is the question, and I have not found it answered plainly anywhere I have looked. Documentation question rather than a pharmacological…	+26	30	1.1k	23h
Analytical identity of BPC-157: a 15-mer with a simple mass Compounds › Repair & healing peptides BPC-157 observational data needs a source preprint Analytical identity of BPC-157: a 15-mer with a simple mass Writing it up because I had to work it out twice and would rather nobody else did. Something about analytical identity of BPC-157 does not reconcile…	+3	7	5.2k	10mo
About the Repair & healing peptides category Compounds › Repair & healing peptides BPC-157 TB-500 observational data Pinned Wiki BPC-157, TB-500 and similar. Mostly preclinical evidence; this subcategory is strict about not overstating it. This post is a community wiki: any member at trust level 3 or above can edit it, and every edit…		4	19k	13mo
TB-500 and thymosin beta-4: the fragment versus the protein — does this still hold? Compounds › Repair & healing peptides TB-500 BPC-157 needs a source Closed TB-500 and thymosin beta-4: the fragment versus the protein — does this still hold? — that is the question, and I have not found it answered plainly anywhere I have looked. Two things I would like separated…	+19	23	4.2k	19mo
Revisiting: Oral versus injected administration claims for BPC-157 Compounds › Repair & healing peptides observational data needs a source TB-500 BPC-157 Solved On the subject in the title: Revisiting: Oral versus injected administration claims for BPC-157 Working notes rather than a conclusion. A follow-up question about Oral versus injected administration claims…	+23	27	7.7k	15mo

Related topics — sharing the tags observational data, TB-500, BPC-157

Topic	Participants	Replies	Views	Activity
Analytical identity of BPC-157: a 15-mer with a simple mass — does this still hold? Compounds › Repair & healing peptides needs a source preprint BPC-157 Analytical identity of BPC-157: a 15-mer with a simple mass — does this still hold? — that is the question, and I have not found it answered plainly anywhere I have looked. The question about Analytical…	+28	33	1.6k	1mo
About the Repair & healing peptides category Compounds › Repair & healing peptides BPC-157 TB-500 observational data Pinned Wiki BPC-157, TB-500 and similar. Mostly preclinical evidence; this subcategory is strict about not overstating it. This post is a community wiki: any member at trust level 3 or above can edit it, and every edit…		4	19k	13mo
CJC-1295 with and without DAC: what the modification does — what changed since Compounds › Secretagogues & GH axis GHRP class observational data CJC-1295 tesamorelin CJC-1295 with and without DAC: what the modification does — what changed since Writing it up because I had to work it out twice and would rather nobody else did. What changes if the standard account of…		4	5.1k	7mo
Why plausible mechanism is not evidence of effect Compounds › Repair & healing peptides TB-500 preprint observational data Solved Closed Asking directly, because I could not find a straight answer: Why plausible mechanism is not evidence of effect What changes if the standard account of plausible mechanism is wrong? I ask because I have been…	+14	18	57k	13mo
Evidence quality in the secretagogue literature: an honest assessment Compounds › Secretagogues & GH axis ipamorelin observational data GHRP class tesamorelin Solved Evidence quality in the secretagogue literature: an honest assessment Writing it up because I had to work it out twice and would rather nobody else did. I have spent a fortnight trying to pin evidence quality…		2	25k	9d